Reduced Oxidative Stress in STEMI Patients Treated by Primary Percutaneous Coronary Intervention and with Antioxidant Therapy: A Systematic Review

Author： Ekeløf Sarah   Jensen Svend   Rosenberg Jacob   Gögenur Ismail  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.28, Iss.2, 2014-04, pp. : 173-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention

By Heeg Bart M.S.  

PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. : 769-782

Adis International

Access to resources Recommend Favorite

Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4604-4609

Bentham Science Publishers

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D.   Keating Gillian M.   Wellington Keri  

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

Oral antiplatelet therapy and percutaneous coronary intervention

By Yan Bryan PY   Clark David J   Ajani Andrew E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 3-12

Informa Healthcare

Access to resources Recommend Favorite

Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

By Curran Monique P.   Keating Gillian M.  

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 2009-2035

Adis International

Access to resources Recommend Favorite